Biotech Distilled

UPDATE: Cingulate (CING) - Institutional Adult Supervision Enters the Boardroom

Biotech Distilled's avatar
Biotech Distilled
Apr 05, 2026
∙ Paid

Biotech Distilled is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Last week, I warned about the expanding Dilution Gap at Cingulate and highlighted a critical stumble: management failed to secure enough retail shareholder votes to approve the full issuance of shares and warrants to Falcon Creek Capital, the institutional investor that just threw them a $12 million lifeline in February.

You might be wondering how an institutional shark reacts when a micro-cap management team fumbles the proxy vote holding up their equity conversion. We just got the answer.

According to an update last week, they don’t just send an angry email — they take a seat at the table.

User's avatar

Continue reading this post for free, courtesy of Biotech Distilled.

Or purchase a paid subscription.
© 2026 Biotech Distilled · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture